Lista de obras -

5q21 deletion is often heterogeneous in prostate cancer

scientific article published on 24 January 2019

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

A population-based analysis of temporal perioperative complication rates after minimally invasive radical prostatectomy

artículo científico publicado en 2011

Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

artículo científico publicado en 2019

Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer

artículo científico publicado en 2006

Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion.

artículo científico publicado en 2017

Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

artículo científico publicado en 2015

Assessment of Biochemical Recurrence Rate in Patients With Pathologically Confirmed Insignificant Prostate Cancer

artículo científico publicado en 2008

Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

scientific article published in Scientific Reports

Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage

artículo científico publicado en 2010

Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum

artículo científico publicado en 2008

Blood transfusions in radical prostatectomy: a contemporary population-based analysis.

artículo científico publicado en 2012

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy

scientific article published on 01 December 2006

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer.

artículo científico publicado en 2013

Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer

scientific article published on 22 December 2009

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

scientific article published on 19 November 2019

Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer

artículo científico publicado en 2014

Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer

artículo científico publicado en 2007

Clinical significance of p53 alterations in surgically treated prostate cancers

artículo científico publicado en 2008

Comparison between complication rates of laser prostatectomy electrocautery transurethral resection of the prostate: A population-based study

artículo científico publicado en 2014

Comparison of 11 Active Surveillance Protocols in Contemporary European Men Treated With Radical Prostatectomy

artículo científico publicado en 2017

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

artículo científico

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram

artículo científico publicado en 2018

Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter

artículo científico publicado en 2007

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

artículo científico publicado en 2017

Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features

scientific article published on 01 October 2008

Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

artículo científico publicado en 2015

Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

scientific article published on 02 November 2015

Delay in nephrectomy and cancer control outcomes in elderly patients with small renal masses

artículo científico publicado en 2014

Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer

artículo científico publicado en 2017

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

artículo científico publicado en 2016

Deletion of 3p13 is a late event linked to progression of : fusion prostate cancer

Deletion of 8p is an independent prognostic parameter in prostate cancer

artículo científico publicado en 2016

Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer

artículo científico publicado en 2018

Development and external validation of an extended 10-core biopsy nomogram

artículo científico publicado en 2006

Development and external validation of an extended repeat biopsy nomogram

artículo científico publicado en 2007

Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology

scientific article published on 22 December 2005

Development and internal validation of preoperative transition zone prostate cancer nomogram

artículo científico publicado en 2006

Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer

scientific article published on 14 September 2009

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

scientific article published on 02 August 2019

Effect of Body Mass Index on Histopathologic Parameters: Results of Large European Contemporary Consecutive Open Radical Prostatectomy Series

artículo científico publicado en 2008

Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy

artículo científico publicado en 2007

Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy.

artículo científico publicado en 2008

Expression and prognostic relevance of annexin A3 in prostate cancer

artículo científico publicado en 2008

Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

scientific article published on 29 November 2019

Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

artículo científico publicado en 2015

External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy

artículo científico publicado en 2009

FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

artículo científico publicado en 2017

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

artículo científico publicado en 2017

Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing scheduled radical prostatectomy

scientific article published on 02 March 2006

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

artículo científico publicado en 2015

HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer.

artículo científico publicado en 2015

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

artículo científico publicado en 2015

Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy

artículo científico publicado en 2009

Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer

artículo científico publicado en 2007

Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility.

artículo científico publicado en 2015

Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.

artículo científico publicado en 2016

High B7-H3 expression is linked to increased risk of prostate cancer progression

artículo científico publicado en 2020

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

artículo científico publicado en 2018

High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer

scientific article published on 18 April 2020

High RSF1 protein expression is an independent prognostic feature in prostate cancer

scientific article published on 05 November 2019

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases

High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens

artículo científico publicado en 2017

High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series

artículo científico publicado en 2006

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer

artículo científico publicado en 2010

High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

artículo científico publicado en 2013

High mitochondria content is associated with prostate cancer disease progression

artículo científico publicado en 2013

High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy

artículo científico publicado en 2013

High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

artículo científico publicado en 2012

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

artículo científico publicado en 2017

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

artículo científico publicado en 2015

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

artículo científico publicado en 2017

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

artículo científico publicado en 2019

Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for active surveillance candidates selection.

artículo científico publicado en 2015

Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer

artículo científico publicado en 2018

Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis

artículo científico publicado en 2009

Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.

artículo científico publicado en 2008

Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer

artículo científico publicado en 2017

Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.

artículo científico publicado en 2017

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer

artículo científico publicado en 2013

Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer

artículo científico publicado en 2012

Long-term cancer control outcomes in patients with biochemical recurrence and the impact of time from radical prostatectomy to biochemical recurrence.

artículo científico publicado en 2018

Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.

artículo científico publicado en 2009

Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

artículo científico publicado en 2018

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

scientific article published on 01 May 2019

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

artículo científico publicado en 2015

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients

artículo científico publicado en 2020

Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse

artículo científico publicado en 2014

Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers

artículo científico publicado en 2020

Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer

artículo científico publicado en 2010

MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.

artículo científico publicado en 2013

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

artículo científico publicado en 2018

Marked gene transcript level alterations occur early during radical prostatectomy

artículo científico publicado en 2007

Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories

artículo científico publicado en 2018

Molecular cancer phenotype in normal prostate tissue

artículo científico publicado en 2008

NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer

artículo científico publicado en 2014

Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy

artículo científico publicado en 2019

Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

scientific article published on 24 December 2019

Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® Guideline

artículo científico publicado en 2017

Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

artículo científico publicado en 2015

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

artículo científico publicado en 2017

Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

artículo científico publicado en 2013

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

artículo científico publicado en 2015

PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer.

artículo científico publicado en 2018

Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy series

artículo científico publicado en 2008

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

artículo científico publicado en 2019

Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study

artículo científico publicado en 2010

Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

artículo científico publicado en 2015

Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer

artículo científico publicado en 2020

Reply

Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients

artículo científico publicado en 2012

SNW1 is a prognostic biomarker in prostate cancer

scientific article published on 01 May 2019

SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence

artículo científico publicado en 2013

Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

artículo científico publicado en 2014

Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation

artículo científico publicado en 2006

Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients

scientific article published on 11 October 2006

TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer

artículo científico publicado en 2014

The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy

artículo científico publicado en 2006

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article

The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer

artículo científico publicado en 2016

The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy

artículo científico publicado en 2010

The presence of prostate cancer on saturation biopsy can be accurately predicted.

artículo científico publicado en 2009

The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression.

artículo científico publicado en 2014

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

artículo científico publicado en 2015

Tumor volume in insignificant prostate cancer: increasing threshold gains increasing risk

artículo científico publicado en 2014

Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy

artículo científico publicado en 2007

Unilateral Prostate Cancer Cannot be Accurately Predicted in Low-Risk Patients

artículo científico publicado en 2009

Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

artículo científico publicado en 2017

Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer

scientific article published on 25 September 2019

Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers

scientific article published on 02 June 2020

Up regulation of the steroid hormone synthesis regulator HSD3B2 is linked to early PSA recurrence in prostate cancer

artículo científico publicado en 2018

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

artículo científico publicado en 2017

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

artículo científico publicado en 2016

Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

artículo científico publicado en 2020

Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer

scientific article published on 25 April 2020

Upregulation of SPDEF is associated with poor prognosis in prostate cancer

artículo científico publicado en 2019

Upregulation of centromere protein F is linked to aggressive prostate cancers

Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers

artículo científico publicado en 2020

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion

scientific article published on 06 March 2020

VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

artículo científico publicado en 2015

Venous thromboembolism after radical prostatectomy: the effect of surgical caseload

artículo científico publicado en 2012

Zonal Origin of Localized Prostate Cancer Does not Affect the Rate of Biochemical Recurrence after Radical Prostatectomy

scientific article published on 28 July 2006

p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.

artículo científico publicado en 2016

Lista de obras de

5q21 deletion is often heterogeneous in prostate cancer

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

A population-based analysis of temporal perioperative complication rates after minimally invasive radical prostatectomy

Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer

Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion.

Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

Assessment of Biochemical Recurrence Rate in Patients With Pathologically Confirmed Insignificant Prostate Cancer

Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage

Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum

Blood transfusions in radical prostatectomy: a contemporary population-based analysis.

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer.

Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer

Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer

Clinical significance of p53 alterations in surgically treated prostate cancers

Comparison between complication rates of laser prostatectomy electrocautery transurethral resection of the prostate: A population-based study

Comparison of 11 Active Surveillance Protocols in Contemporary European Men Treated With Radical Prostatectomy

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

Comprehensive Characterization of Cancer Driver Genes and Mutations

Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram

Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features

Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

Delay in nephrectomy and cancer control outcomes in elderly patients with small renal masses

Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

Deletion of 3p13 is a late event linked to progression of : fusion prostate cancer

Deletion of 8p is an independent prognostic parameter in prostate cancer

Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer

Development and external validation of an extended 10-core biopsy nomogram

Development and external validation of an extended repeat biopsy nomogram

Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology

Development and internal validation of preoperative transition zone prostate cancer nomogram

Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

Effect of Body Mass Index on Histopathologic Parameters: Results of Large European Contemporary Consecutive Open Radical Prostatectomy Series

Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy

Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy.

Expression and prognostic relevance of annexin A3 in prostate cancer

Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy

FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing scheduled radical prostatectomy

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer.

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy

Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer

Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility.

Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.

High B7-H3 expression is linked to increased risk of prostate cancer progression

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer

High RSF1 protein expression is an independent prognostic feature in prostate cancer

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases

High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens

High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer

High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

High mitochondria content is associated with prostate cancer disease progression

High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy

High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for active surveillance candidates selection.

Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer

Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis

Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.

Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer